Profund Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,664
Closed -$1.47M 1169
2023
Q3
$1.47M Sell
12,664
-2,197
-15% -$254K 0.08% 193
2023
Q2
$1.53M Buy
14,861
+3,625
+32% +$373K 0.08% 197
2023
Q1
$1.23M Sell
11,236
-14,041
-56% -$1.53M 0.08% 248
2022
Q4
$2.88M Buy
25,277
+156
+0.6% +$17.8K 0.19% 105
2022
Q3
$1.56M Sell
25,121
-1,146
-4% -$70.9K 0.11% 164
2022
Q2
$2.1M Sell
26,267
-1,990
-7% -$159K 0.13% 139
2022
Q1
$2.97M Sell
28,257
-2,933
-9% -$309K 0.12% 141
2021
Q4
$3.36M Sell
31,190
-5,440
-15% -$586K 0.11% 153
2021
Q3
$4.01M Sell
36,630
-1,731
-5% -$190K 0.14% 132
2021
Q2
$3.59M Buy
38,361
+26,715
+229% +$2.5M 0.12% 145
2021
Q1
$1.07M Sell
11,646
-3,382
-23% -$311K 0.04% 296
2020
Q4
$1.1M Buy
15,028
+1,748
+13% +$128K 0.05% 294
2020
Q3
$1.03M Sell
13,280
-4,408
-25% -$343K 0.05% 274
2020
Q2
$983K Buy
17,688
+2,218
+14% +$123K 0.05% 272
2020
Q1
$458K Sell
15,470
-144
-0.9% -$4.26K 0.03% 385
2019
Q4
$565K Buy
15,614
+1,882
+14% +$68.1K 0.02% 559
2019
Q3
$374K Sell
13,732
-2,970
-18% -$80.9K 0.02% 773
2019
Q2
$402K Sell
16,702
-4,398
-21% -$106K 0.02% 761
2019
Q1
$558K Sell
21,100
-2,132
-9% -$56.4K 0.03% 582
2018
Q4
$454K Sell
23,232
-7,675
-25% -$150K 0.03% 516
2018
Q3
$605K Buy
+30,907
New +$605K 0.02% 649
2018
Q2
Sell
-10,745
Closed -$153K 1538
2018
Q1
$153K Sell
10,745
-485
-4% -$6.91K 0.01% 1409
2017
Q4
$164K Sell
11,230
-1,625
-13% -$23.7K 0.01% 1399
2017
Q3
$163K Buy
12,855
+479
+4% +$6.07K 0.01% 1376
2017
Q2
$147K Sell
12,376
-1,132
-8% -$13.4K 0.01% 1374
2017
Q1
$200K Buy
13,508
+112
+0.8% +$1.66K 0.01% 1383
2016
Q4
$217K Sell
13,396
-562
-4% -$9.1K 0.01% 1420
2016
Q3
$253K Buy
13,958
+2,206
+19% +$40K 0.01% 1194
2016
Q2
$194K Buy
+11,752
New +$194K 0.01% 1357
2016
Q1
Sell
-10,790
Closed -$234K 1500
2015
Q4
$234K Sell
10,790
-958
-8% -$20.8K 0.01% 1117
2015
Q3
$233K Buy
+11,748
New +$233K 0.01% 1007